Results 41 patients with COPD were recruited (PLB n¼22, control n¼19); mean (SD) age 68 (11) years, mean (SD) FEV 1 % predicted 47 (15.80)%. There was no statistically significant difference between groups in the primary outcome measures and in retrospect the RCT was insufficiently powered. Post hoc analysis found effect sizes for primary outcome measures were: CRQ-SR dyspnoea 0.05, mastery 0.48 and ESWT 0.44. For secondary outcome measures unpaired ttest showed a significant (p¼0.02) reduction in oxygen desaturation on ESWT in favour of PLB group. Conclusion This study showed PLB practised over 8 weeks resulted in reduced physiological stress with respect to oxygen desaturation when performing a standardised endurance walk. Additionally it raises questions regarding use of a health related quality of life dyspnoea tool when investigating PLB. To date beneficial effect of PLB on dyspnoea related to exercise has only been shown using the Borg breathlessness score (Nield et al, 2007).
Background Patients with severe acute exacerbations of COPD (AECOPD) often require treatment with non-invasive ventilation (NIV). The BTS audit reported that patients who develop respiratory acidosis and require NIV after 24 h in hospital have a high mortality risk but this relationship has not been investigated prospectively.
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Methods Consecutive patients hospitalised with AECOPD and receiving assisted ventilation (NIV or IPPV) were identified. Demographic information, time from admission to commencement of ventilation, arterial blood gases at admission and at time of development of respiratory acidosis (if different), and outcomes of treatment were recorded. Results 195 of 920 patients admitted with AECOPD were initially treated with NIV and four were ventilated invasively. Mean (SD) age was 73.6 (9.8) years, and most: were female (61.4%); had experienced frequent exacerbations in the previous year (median 3, IQR 1e4); were of normal weight (mean (SD) BMI 25.1 (7.0) kg/m 2 ); and had severe airflow obstruction (mean (SD) FEV 1 38.1 (16.1) % predicted). 27.6% of patients had received NIV previously for treatment of AECOPD, and 81 (40.7%) patients had coexistent pneumonia on admission.
Median duration of ventilation was 4 days (IQR 1.5e5) and four of the patients who initially received NIV progressed to invasive ventilation. 49 (24.6%) patients died in-hospital. The risk of death increased with longer time from hospital admission to ventilation commencement (Abstract P266 figure 1), with more than 60% of patients who required ventilation after day 2 of their hospital admission not surviving to discharge. Conclusion Mortality in AECOPD is particularly high in patients who deteriorate and require ventilation after day 2 of the admission. The time from admission to needing ventilation (NIV or IPPV) should inform clinicians considering the prognosis of patients hospitalised with AECOPD. Introduction COPD is a leading cause of mortality and morbidity and timely use of NIV improves outcomes. National guidelines recommend early intervention in persisting acidosis however, audit data suggests that many patients receive NIV late and have high mortality compared to the results of RCTs. We aimed to improve the process of care for these patients through the introduction of a prospective proforma, prompting clinicians to follow guideline recommendations about timely intervention. Methods The proforma included items that prompted: care in medications being given, ABGs being taken and decisions regarding escalation of care and resuscitation status being made. All emergency COPD exacerbations managed with NIV were included in the study. Data were collected prospectively for 7.5 months in seven Acute Trusts in London and Essex. Each site was given real time feedback on their performance on a monthly basis. Results The proforma was used in 138 acidotic COPD patients managed with NIV. Combined data from all the involved sites demonstrated no significant improvement in door-to-mask times during the study period. Overall only 47% of patients received NIV within 3 h of admission and there was significant variation between individual sites in door-to-mask times (p¼0.0007, Abstract P268 table 1). Sites were grouped according to their respiratory on call system. Sites with a 9-5 respiratory on call had the shortest door-to-mask time, both during 9:00e17:00 and out of hours, mean time¼203.5 min (SD 259), vs 291.9 min (SD 231.9) for 24 h respiratory on call and 327 min (SD 314.7) for those without a respiratory on call. Patients who were started on NIV in locations outside A&E had longer mean door to-mask-times (135.62 vs 377.44 min). Conclusion The introduction of a proforma with monthly feedback reports did not improve door-to-mask times. Less than half the patients managed with NIV received this within 3 h. There remains an unacceptable variation in the standard of patient care that may result from different operational practices across hospitals. There is a need to define optimal service delivery to ensure that all patients receive best care regardless of their place of admission. Introduction Patients with acute exacerbations of chronic respiratory disease are often too breathless to exercise, leading to muscle deconditioning. Using NIV to assist exercise during an exacerbation might prevent this, but it is not known if this is acceptable to patients.
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P269 FEASIBILITY AND ACCEPTABILITY OF NON-INVASIVE VENTILATION (NIV) AS AN AID TO EXERCISE IN PATIENTS ADMITTED WITH ACUTE EXACERBATION OF CHRONIC
Methods 12 in-patients with an acute exacerbation (including Bronchiectasis and CF) were recruited. If they were unable to cycle for 5 min at 20 Watts unassisted they then cycled with NIV for up to 20 min. NIV settings were adjusted to patient comfort. Patients were asked to rate their level of distress and willingness to repeat the intervention.
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